VX-984
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-19939S-5MG | 5 mg | 710,00 | Add | |
| HY-19939S-1ML | 10mM/1mL | 780,00 | Add | |
| HY-19939S-10MG | 10 mg | 1'217,00 | Add | |
| HY-19939S-50MG | 50 mg | 5'017,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
VX-984 is an orally active, potent, selective and BBB-penetrated DNA-PK inhibitor. VX-984 efficiently inhibits NHEJ (non-homologous end joining) and increases DSBs (DNA double-strand breaks). VX-984 can be used for glioblastomas (GBM) and non-small cell lung cancer (NSCLC) research. VX-984 is a de novo deuterium[1][2][3].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Application | Isotope-labeled compound |
| Regulatory Status | RUO |
| Research Field | Cancer, Cell Cycle/DNA Damage,PI3K/Akt/mTOR |
| Format | Solubility: DMSO : 10 mg/mL (ultrasonic) |
| Grade | Clinical information: Phase 1 |
| Purity | 98.86% |
| Molecular Formula | C23H21D2N7O |
| Molecular Weight | 415.49 |
| CAS-Number | 1476074-39-1 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
